‘An ounce of prevention is worth a pound of cure’: the case for and against GnRH-agonist for fertility preservation

The late effects of cancer treatment have recently gained a worldwide interest among reproductive endocrinologists, oncologists, and all health-care providers, and the protection against iatrogenic infertility caused by chemotherapy assumes a high priority. Here, we summarize the case for and agains...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of oncology 2014-09, Vol.25 (9), p.1719-1728
Hauptverfasser:	Blumenfeld, Z., Katz, G., Evron, A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antineoplastic agents Antineoplastic Agents - adverse effects Antineoplastic Agents - therapeutic use Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Female Fertility - drug effects fertility preservation Fertility Preservation - methods GnRH-agonist gonadotoxicity Gonadotropin-Releasing Hormone - agonists Humans Medical sciences Middle Aged Neoplasms - drug therapy Ovary - physiology Pharmacology. Drug treatments POF Pregnancy Primary Ovarian Insufficiency - prevention & control Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!